Lewis, A <br/><br/>
Budesonide + formoterol delivered via Spiromax  [electronic resource] 

 -  Respiratory medicine  08 2017 
 - 179-188 p.  digital 
<br/><br/> Publication Type: Journal Article 
<br/><br/><label>ISSN: </label>1532-3064 
<br/><br/><label>Standard No.: </label>10.1016/j.rmed.2017.06.018  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Administration, Inhalation<br/>Adrenergic beta-2 Receptor Agonists--therapeutic use<br/>Asthma--drug therapy<br/>Bronchodilator Agents--therapeutic use<br/>Budesonide--administration & dosage<br/>Budesonide, Formoterol Fumarate Drug Combination--administration & dosage<br/>Dry Powder Inhalers--economics<br/>Formoterol Fumarate--administration & dosage<br/>Germany<br/>Glucocorticoids--therapeutic use<br/>Health Care Costs--trends<br/>Humans<br/>Italy<br/>Pulmonary Disease, Chronic Obstructive--drug therapy<br/>Sweden